Vitruvias Therapeutics Thyroid Tablet Recall: Risks, Superpotency & Safety Guide
If you or a loved one relies on daily thyroid medication, a recent safety announcement requires your immediate attention. Vitruvias Therapeutics, Inc. has issued a voluntary nationwide recall for a specific batch of its thyroid hormone replacement product due to critical manufacturing concerns involving "superpotency" risks.
At YogVistaar, we care deeply about holistic health, lifestyle safety, and informed medical choices. Whether you are managing an underactive thyroid or looking into natural wellness pathways like our Therapeutic Yoga Programs, staying updated on pharmaceutical alerts is vital for safeguarding your health.
💡 Quick Summary: What is the Vitruvias Thyroid Recall?
Vitruvias Therapeutics recalled Thyroid Tablets USP 30 mg (Lot 504950) because the pills can be superpotent—containing higher active hormone levels than labeled. This can induce hyperthyroidism symptoms. Check your medicine bottles immediately and consult your physician.
Recalled Product Specifications & Lot Details
The recall affects strictly a single batch of medication. Review your medicine labels or pharmacy bottles against the following official specifications:
- Product Name: Thyroid Tablets, USP 30 mg
- National Drug Code (NDC): 69680-166-00
- Affected Lot Number: 504950
- Expiration Date: September 30, 2026
- Distribution Window: Distributed nationwide between January 31, 2025, and September 30, 2025
Symptoms of Taking Too Much Thyroid Hormone Medication
When thyroid pills contain higher-than-intended hormone amounts (levothyroxine/T4 and liothyronine/T3), it exposes the body to unexpected excess, driving the patient into a state of acute hyperthyroidism. Watch out for these primary warning signs:
Common Side Effects of Superpotent Thyroid Pills
Hyperthyroidism Risks- Rapid or Irregular Heartbeat: Experiencing palpitations or tachycardia (racing heart).
- Cardiovascular Strain: Sudden high blood pressure or unexpected chest discomfort.
- Nervous System Changes: Heightened anxiety, nervousness, irritability, or trembling hands.
- Metabolic Shifts: Unexplained weight loss, excessive sweating, and severe heat intolerance.
- Physical Exhaustion: Persistent fatigue coupled with muscle weakness.
Elderly individuals, pregnant women, and infants face extreme medical risks if exposed to prolonged superpotent hormone doses, as it places severe stress on heart function and fetal development.
- Verify your bottle's lot number right away.
- Consult your doctor before altering intake.
- Do not abruptly stop your medicine on your own.
- Do not ignore rapid heart rate symptoms.
Normal Dosage vs. Superpotent Exposure Overview
Understanding how standard hypothyroid treatment compares to an accidental high-potency batch exposure:
| Metric | Normal Prescribed Dose | Superpotent Pill Exposure (Lot 504950) |
|---|---|---|
| Hormone Level | Balanced to match body's baseline needs | Excessive T3/T4 hormone concentration |
| Body Impact | Regulates metabolism smoothly | Triggers acute hyperthyroidism symptoms |
| Cardiac Effect | Stable heart rhythm | Potential tachycardia, palpitations, chest pain |
| Action Required | Continue routine prescription | Immediate batch check & physician consultation |
Frequently Asked Questions (FAQs)
Ans: The recall applies to Thyroid Tablets, USP 30 mg, under National Drug Code (NDC) 69680-166-00, specifically Lot Number 504950 with an expiry date of September 30, 2026.
Ans: No. Stopping thyroid hormone medication abruptly can cause severe hypothyroid symptoms to return. Always speak with your healthcare provider first for a safe replacement plan.
Ans: You can reach Vitruvias Therapeutics via email at safety@vitruvias.com or call (256) 239-9373. Adverse reactions can also be submitted directly to the FDA MedWatch program.